Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Bellen Chemistry of Beijing, a CRO/CMO, Raises $30 Million-Plus in C Round

publication date: Sep 27, 2018

Bellen Chemistry, a Beijing CRO/CMO, raised "hundreds of millions in RMB" ($30 million plus) in a C financing round. The company offers chemical synthesis for chemical drugs based on its large library of heterocycles. Founded in 2007, Bellen has its headquarters and a research lab in Beijing, a research center in Shanghai, and a manufacturing base in Shandong province. The round was led by Apricot Capital, CMB and Qianhai Fund of Funds. One year ago, Bellen completed a $38 million B financing intended mainly for its manufacturing operations. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital